Cell, Volume 150, Issue 2, 351-365, 20 July 2012. Non-canonical Wnt signaling maintains hematopoietic stem cells in the niche.Sugimura R, He XC, Venkatraman A, Arai F, Box A, Semerad C, Haug JS, Peng L, Zhong X, Suda Tand Li L.
Blood. 2012 Aug 30;120(9):1831-42. FGF signaling facilitates post-injury recovery of mouse hematopoietic system. Zhao M, Ross JT, Itkin T, Perry JM, Venkatraman A, Haug JS, Hembree M, Deng C-X, Lapidot Y, He XC, and Li L.
Blood Cells Mol Dis. 2012 Jun 15;49(1):11-9.Inflammation-induced effects on iron-related proteins in splenic macrophages and the liver in mice. Sukumaran A, Venkatraman A, Jacob M.
Vaccine. 2012 Jun 6;30(26):3908-17.High-efficiency transduction of human monocyte-derived dendritic cells by capsid-modified recombinant AAV2 vectors. Aslanidi GV, Rivers AE, Ortiz L, Govindasamy L, Ling C, Jayandharan GR, Zolotukhin S, Agbandje-McKenna M, Srivastava A.
SemThrombHaemost 2012; 38(1):64-78. Application of molecular genetics in haemophilia: from diagnoses to therapy. Jayandharan GR, Srivastava A, Srivastava A.
Cell Stem Cell. 2012 Feb 3;10(2):149-50.Advancing stem cell biology toward stem cell therapeutics. Scadden D, Srivastava A.
Bone.2012 Apr;50(4):1012-8. Epub 2012 Feb 9.Mobilization of bone marrow mesenchymal stem cells in vivo augments bone healing in a mouse model of segmental bone defect. Kumar S, Ponnazhagan S.
Semin Thromb Hemost. 2012 Feb;38(1):64-78. Role of molecular genetics in hemophilia: from diagnosis to therapy. Jayandharan GR, Srivastava A, Srivastava A.
J Genet Syndr Gene Ther. 2012 January 10; Suppl 1: 008. Development of Novel Recombinant AAV Vectors and Strategies for the Potential Gene Therapy of Hemophilia. Zhong L, Jayandharan GR, Aslanidi G, Zolutukin S, Herzog RW, Srivastava A.
Stem Cells International, Volume 2012 (2012), Article ID 174328, 11 pages. Long-Term Cultured Human Term Placenta-Derived Mesenchymal Stem Cells of Maternal Origin Displays Plasticity. V.Sabapathy, S. Ravi, V. Srivastava, A.Srivastava, and S.Kumar